These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1650194)

  • 1. 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) and 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide (EICAR) markedly potentiate the inhibitory effect of 2',3'-dideoxyinosine on human immunodeficiency virus in peripheral blood lymphocytes.
    Balzarini J; Lee CK; Schols D; De Clercq E
    Biochem Biophys Res Commun; 1991 Jul; 178(2):563-9. PubMed ID: 1650194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depletion of GTP pool is not the predominant mechanism by which ribavirin exerts its antiviral effect on Lassa virus.
    Ölschläger S; Neyts J; Günther S
    Antiviral Res; 2011 Aug; 91(2):89-93. PubMed ID: 21616094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eicar (5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide). A novel potent inhibitor of inosinate dehydrogenase activity and guanylate biosynthesis.
    Balzarini J; Karlsson A; Wang L; Bohman C; Horská K; Votruba I; Fridland A; Van Aerschot A; Herdewijn P; De Clercq E
    J Biol Chem; 1993 Nov; 268(33):24591-8. PubMed ID: 7901217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral efficacy of EICAR against canine distemper virus (CDV) in vitro.
    Dal Pozzo F; Galligioni V; Vaccari F; Gallina L; Battilani M; Scagliarini A
    Res Vet Sci; 2010 Apr; 88(2):339-44. PubMed ID: 19781726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of the potentiating effect of ribavirin on the activity of 2',3'-dideoxyinosine against human immunodeficiency virus.
    Balzarini J; Lee CK; Herdewijn P; De Clercq E
    J Biol Chem; 1991 Nov; 266(32):21509-14. PubMed ID: 1939181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism-based design of inosine 5-monophosphate dehydrogenase inhibitors: synthesis and biological activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide (EICAR) and its derivatives.
    Minakawa N; Matsuda A
    Curr Med Chem; 1999 Jul; 6(7):615-28. PubMed ID: 10390604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral activities of ribavirin, 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide, and 6'-(R)-6'-C-methylneplanocin A against several ortho- and paramyxoviruses.
    Shigeta S; Mori S; Baba M; Ito M; Honzumi K; Nakamura K; Oshitani H; Numazaki Y; Matsuda A; Obara T
    Antimicrob Agents Chemother; 1992 Feb; 36(2):435-9. PubMed ID: 1605607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase.
    Leyssen P; Balzarini J; De Clercq E; Neyts J
    J Virol; 2005 Feb; 79(3):1943-7. PubMed ID: 15650220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Amino-4-imidazolecarboxamide riboside potentiates the metabolism and anti-human immunodeficiency virus activity of 2',3'-dideoxyinosine.
    Gong YF; Srinivas RV; Fridland A
    Mol Pharmacol; 1993 Jul; 44(1):30-6. PubMed ID: 8341276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of infectious pancreatic necrosis virus (IPNV) replication.
    Jashés M; González M; López-Lastra M; De Clercq E; Sandino A
    Antiviral Res; 1996 Mar; 29(2-3):309-12. PubMed ID: 8739609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4- carboxamide and related compounds.
    De Clercq E; Cools M; Balzarini J; Snoeck R; Andrei G; Hosoya M; Shigeta S; Ueda T; Minakawa N; Matsuda A
    Antimicrob Agents Chemother; 1991 Apr; 35(4):679-84. PubMed ID: 2069373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of EICAR on infectious pancreatic necrosis virus replication.
    Jashés M; Mlynarz G; De Clercq E; Sandino AM
    Antiviral Res; 2000 Jan; 45(1):9-17. PubMed ID: 10774586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of pyrimidine metabolism in myeloid leukemia cells by triazole and pyrazole nucleosides.
    Matsumoto SS; Fujitaki JM; Nord LD; Willis RC; Lee VM; Sharma BS; Sanghvi YS; Kini GD; Revankar GR; Robins RK
    Biochem Pharmacol; 1990 Feb; 39(3):455-62. PubMed ID: 1968339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin.
    Barnard DL; Day CW; Bailey K; Heiner M; Montgomery R; Lauridsen L; Winslow S; Hoopes J; Li JK; Lee J; Carson DA; Cottam HB; Sidwell RW
    Antiviral Res; 2006 Aug; 71(1):53-63. PubMed ID: 16621037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of IMP dehydrogenase stimulate the phosphorylation of the anti-human immunodeficiency virus nucleosides 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine.
    Hartman NR; Ahluwalia GS; Cooney DA; Mitsuya H; Kageyama S; Fridland A; Broder S; Johns DG
    Mol Pharmacol; 1991 Jul; 40(1):118-24. PubMed ID: 1677450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective guanosine phosphate deficiency in hepatoma cells induced by inhibitors of IMP dehydrogenase.
    Kaiser WA; Herrmann B; Keppler DO
    Hoppe Seylers Z Physiol Chem; 1980 Oct; 361(10):1503-10. PubMed ID: 6108911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assay method for monitoring the inhibitory effects of antimetabolites on the activity of inosinate dehydrogenase in intact human CEM lymphocytes.
    Balzarini J; De Clercq E
    Biochem J; 1992 Nov; 287 ( Pt 3)(Pt 3):785-90. PubMed ID: 1359876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiating effect of (2-[2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methyl]-phenyl]ethenyl) -phosphonic acid (MDL 74,428), a potent inhibitor of purine nucleoside phosphorylase, on the antiretroviral activities of 2',3'-dideoxyinosine combined with ribavirin in mice.
    Weibel M; Balzarini J; Bernhardt A; Mamont P
    Biochem Pharmacol; 1994 Jul; 48(2):245-52. PubMed ID: 8053921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anti-yellow fever virus activity of ribavirin is independent of error-prone replication.
    Leyssen P; De Clercq E; Neyts J
    Mol Pharmacol; 2006 Apr; 69(4):1461-7. PubMed ID: 16421290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of EICAR (5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide), a potent inhibitor of inosinate dehydrogenase.
    Balzarini J; Stet L; Matsuda A; Wiebe L; Knauss E; De Clercq E
    Adv Exp Med Biol; 1998; 431():723-8. PubMed ID: 9598159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.